Association of RMND1/CCDC170–ESR1 single nucleotide polymorphisms with hip fracture and osteoporosis in postmenopausal women


Por: Hidalgo-Bravo A., Parra-Torres A.Y., Casas-Avila L., Jimenez-Ortega R.F., Ramírez-Salazar E.G., Patiño N., Rivera-Paredez B., Salmerón J., Valdés-Flores M., Velázquez-Cruz R.

Publicada: 2 ene 2019 Ahead of Print: 1 ene 2018
Resumen:
Objective: This study aimed to investigate the association of seven single nucleotide polymorphisms (SNPs) on the RMND1, CCDC170, and ESR1 genes with osteoporosis or hip fracture in a postmenopausal Mexican population. Methods: We included a group of 400 postmenopausal women from the Health Workers Cohort Study from the Mexican Institute of Social Security. As a replication sample, we recruited 423 postmenopausal women from the National Institute of Rehabilitation. Demographic data were collected through a structured questionnaire. Bone mineral density was assessed using dual X-ray absorptiometry. Individuals were classified as normal, osteopenia, osteoporosis, and fracture, according to World Health Organization criteria. Genotyping was performed using predesigned TaqMan Probes. Linear regression analysis was used to investigate association. Results: All of the analyzed SNPs showed association with at least one of the phenotypes of the study groups. In addition, we observed a region with linkage disequilibrium within the ESR1 gene in all groups. Conclusion: This study shows that an association of the SNPs can exist with osteopenia, osteoporosis, or fragility fracture. Our results agree with data published elsewhere, supporting the potential of these loci for the identification of the population at risk. However, additional studies are required to determine the extent of this association for other geographic regions of Mexico. © 2018, © 2018 International Menopause Society.

Filiaciones:
Hidalgo-Bravo A.:
 Department of Genetics, National Institute of Rehabilitation, Mexico City, Mexico

 Natl Inst Rehabil, Dept Genet, Mexico City, DF, Mexico

Parra-Torres A.Y.:
 Genomics of Bone Metabolism Laboratory, National Institute of Genomic Medicine (INMEGEN), Mexico City, Mexico

 Natl Inst Genom Med INMEGEN, Genom Bone Metab Lab, Perifer Sur 4809, Mexico City 14610, DF, Mexico

Casas-Avila L.:
 Department of Genetics, National Institute of Rehabilitation, Mexico City, Mexico

 Natl Inst Rehabil, Dept Genet, Mexico City, DF, Mexico

Jimenez-Ortega R.F.:
 Genomics of Bone Metabolism Laboratory, National Institute of Genomic Medicine (INMEGEN), Mexico City, Mexico

 Natl Inst Genom Med INMEGEN, Genom Bone Metab Lab, Perifer Sur 4809, Mexico City 14610, DF, Mexico

Ramírez-Salazar E.G.:
 Genomics of Bone Metabolism Laboratory, National Institute of Genomic Medicine (INMEGEN), Mexico City, Mexico

 National Council for Science and Technology (CONACYT) - Genomics of Bone Metabolism Laboratory, National Institute of Genomic Medicine (INMEGEN), Mexico City, Mexico

 Natl Inst Genom Med INMEGEN, Genom Bone Metab Lab, Perifer Sur 4809, Mexico City 14610, DF, Mexico

 Natl Inst Genom Med INMEGEN, Natl Council Sci & Technol CONACYT, Genom Bone Metab Lab, Mexico City, DF, Mexico

Patiño N.:
 Subdirection of Development of Clinical Applications, National Institute of Genomic Medicine (INMEGEN), Mexico City, Mexico

Rivera-Paredez B.:
 Academic Unit in Epidemiological Research, Research Center in Policies, Population and Health, School of Medicine, National Autonomous University of Mexico, Mexico City, Mexico

 Univ Nacl Autonoma Mexico, Sch Med, Res Ctr Policies Populat & Hlth, Acad Unit Epidemiol Res, Mexico City, DF, Mexico

Salmerón J.:
 Academic Unit in Epidemiological Research, Research Center in Policies, Population and Health, School of Medicine, National Autonomous University of Mexico, Mexico City, Mexico

 Center for Population Health Research, National Institute of Public Health (INSP), Cuernavaca, Mexico

 Univ Nacl Autonoma Mexico, Sch Med, Res Ctr Policies Populat & Hlth, Acad Unit Epidemiol Res, Mexico City, DF, Mexico

 Natl Inst Publ Hlth INSP, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico

Valdés-Flores M.:
 Department of Genetics, National Institute of Rehabilitation, Mexico City, Mexico

 Natl Inst Rehabil, Dept Genet, Mexico City, DF, Mexico

Velázquez-Cruz R.:
 Genomics of Bone Metabolism Laboratory, National Institute of Genomic Medicine (INMEGEN), Mexico City, Mexico

 Natl Inst Genom Med INMEGEN, Genom Bone Metab Lab, Perifer Sur 4809, Mexico City 14610, DF, Mexico

Natl Inst Genom Med INMEGEN, Subdirect Dev Clin Applicat, Mexico City, DF, Mexico
ISSN: 13697137
Editorial
INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 22 Número: 1
Páginas: 97-104
WOS Id: 000458564000018
ID de PubMed: 30601066

MÉTRICAS